In whom and how to prevent glucocorticoid-induced osteoporosis Journal Articles

abstract

• Glucocorticoid use is widespread in medicine. While it is often life-saving, side-effects are well known. The most common side-effect is osteoporosis. Today we have therapies with proven efficacy for the prevention of vertebral fractures and bone loss. Consequently recognition of glucocorticoid-induced osteoporosis is extremely important given the availability of effective therapy.

authors

• Adachi, Jonathan Derrick
• Papaioannou, Alexandra

status

• published 

publication date

• December 2005

has subject area

• 1103 Clinical Sciences (FoR)
• 1117 Public Health and Health Services (FoR)
• Arthritis & Rheumatology (Science Metrix)
• Bone Density (MeSH)
• Bone Density Conservation Agents (MeSH)
• Calcitonin (MeSH)
• Calcium, Dietary (MeSH)
• Diphosphonates (MeSH)
• Fluorides (MeSH)
• Glucocorticoids (MeSH)
• Hormone Replacement Therapy (MeSH)
• Humans (MeSH)
• Life Style (MeSH)
• Osteoporosis (MeSH)
• Risk Factors (MeSH)
• Vitamin D (MeSH)

published in

• Best Practice and Research in Clinical Rheumatology  Journal

keywords

• Bone Density
• Bone Density Conservation Agents
• Calcitonin
• Calcium, Dietary
• Diphosphonates
• Fluorides
• Glucocorticoids
• Hormone Replacement Therapy
• Humans
• Life Style
• Osteoporosis
• Risk Factors
• Vitamin D

Digital Object Identifier (DOI)

• 10.1016/j.berh.2005.07.002

PubMed ID

• 16301196

start page

• 1039

end page

• 1064

volume

• 19

issue

• 6